Efficacy and Safety of Baricitinib for the Treatment of Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT05660655 · COMPLETED
Trial details
- NCT number
- NCT05660655
- Sponsor
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2023-09-30
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.